Table 1.
Age | |
Median | 62.0 |
Range | 41–82 |
Gender, n (%) | |
Female | 17 (43.6) |
Male | 22 (56.4) |
Performance status, n (%) | |
0 | 17 (43.6) |
1 | 22 (56.4) |
Stage, n (%) | |
IIIB | 5 (12.8) |
IV | 34 (87.2) |
Brain metastases, n (%) | |
No | 35 (89.7) |
Yes | 4 (10.3) |
Histology, n (%) | |
Squamous | 1 (2.6)a |
Nonsquamous | 38 (97.4) |
Nonsquamous detail, n (%) | |
Adenocarcinoma | 32 (82.0) |
Large cell | 2 (5.1) |
Bronchioloalveolar | 1 (2.6) |
NSCLC, NOS | 3 (7.7) |
Abbreviation: NSCLC, NOS = non–small-cell lung cancer, not otherwise specified.
The study allowed squamous cell if the primary tumor had been resected.